首页> 外文期刊>Expert Opinion on Therapeutic Patents >Multicomponent reactions (MCR) in medicinal chemistry: a patent review(2010-2020)
【24h】

Multicomponent reactions (MCR) in medicinal chemistry: a patent review(2010-2020)

机译:药物化学中的多组分反应(MCR):专利综述(2010-2020)

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Multicomponent reactions (MCR) has been utilized to synthesize a vast range of analogs belonging to diverse classes of heterocyclic compounds offering multidimensional pharmaceutical applications. The unique feature of MCR includes the synthesis of highly functionalized molecules in a single pot to build quick libraries of compounds of biological interest to identify new leads as potential therapeutic agents.Area covered: The current review article covers the patents published in the last decade in order to highlight the importance of multicomponent reactions for synthesizing complex-functionalized molecules of high biological significance.Expert opinion: Easily automated one-pot multicomponent reactions (MCRs) has demonstrated successful impact at different stages of the lead discovery, lead optimization, and pre-clinical process development arenas. Application of MCRs is the recent advancement in the field of drug design and discovery which will expectedly lead to the development of medicinally important heterocyclic compounds with a vast range of biological activities.
机译:引言:已经利用多组分反应(MCR)来合成属于多维药物应用的各种杂环化合物的多种类似物。 MCR的独特特征包括在单个锅中合成高官能化分子,以构建生物利益化合物的快速文库,以识别新的铅作为潜在的治疗剂.AREA涵盖:当前审查文章涵盖了在过去十年中发表的专利为了突出多组分反应的重要性,用于合成高生物意义的复合官能化分子。普及意见:易于自动化的一盆多组分反应(MCR)在铅发现,铅优化和预先进行的不同阶段表现出了成功的影响临床过程开发竞技场。 MCR的应用是近期药物设计和发现领域的进步,预计将导致药用的杂环化合物的发展,具有广泛的生物活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号